These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 38123920

  • 1. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
    Roca M, Masip E, Colombo C, Boon M, Hulst JM, Garriga M, de Koning BAE, Bulfamante A, de Boeck K, Ribes-Koninckx C, Calvo-Lerma J.
    Arch Dis Child; 2024 Jun 19; 109(7):552-556. PubMed ID: 38123920
    [Abstract] [Full Text] [Related]

  • 2. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
    Calvo-Lerma J, Roca M, Boon M, Colombo C, de Koning B, Fornés-Ferrer V, Masip E, Garriga M, Bulfamante A, Asensio-Grau A, Andrés A, de Boeck K, Hulst J, Ribes-Koninckx C.
    Pediatr Res; 2021 Jan 19; 89(1):205-210. PubMed ID: 32247283
    [Abstract] [Full Text] [Related]

  • 3. Intestinal inflammation and impact on growth in children with cystic fibrosis.
    Dhaliwal J, Leach S, Katz T, Nahidi L, Pang T, Lee JM, Strachan R, Day AS, Jaffe A, Ooi CY.
    J Pediatr Gastroenterol Nutr; 2015 Apr 19; 60(4):521-6. PubMed ID: 25539196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.
    Więcek S, Chudek J, Woś H, Bożentowicz-Wikarek M, Kordys-Darmolinska B, Grzybowska-Chlebowczyk U.
    Dis Markers; 2018 Apr 19; 2018():5940893. PubMed ID: 30116405
    [Abstract] [Full Text] [Related]

  • 7. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
    Boon M, Calvo-Lerma J, Claes I, Havermans T, Asseiceira I, Bulfamante A, Garriga M, Masip E, van Schijndel BAM, Fornes V, Barreto C, Colombo C, Crespo P, Vicente S, Janssens H, Hulst J, Witters P, Nobili R, Pereira L, Ruperto M, Van der Wiel E, Mainz JG, De Boeck K, Ribes-Koninckx C.
    J Cyst Fibros; 2020 Jul 19; 19(4):562-568. PubMed ID: 32335023
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a Cystic Fibrosis Enteropathy.
    Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC.
    PLoS One; 2015 Jul 19; 10(10):e0138062. PubMed ID: 26484665
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T, Leach ST, Katz T, Jaffe A, Day AS, Ooi CY.
    J Gastroenterol Hepatol; 2015 May 19; 30(5):866-71. PubMed ID: 25376228
    [Abstract] [Full Text] [Related]

  • 11. Evidence of intestinal inflammation in patients with cystic fibrosis.
    Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J, Malka N, Cohen L, Armoni S, Yatzkan-Israelit Y, Bergwerk A, Aviram M, Bentur L, Mussaffi H, Bjarnasson I, Wilschanski M.
    J Pediatr Gastroenterol Nutr; 2010 Sep 19; 51(3):304-8. PubMed ID: 20512061
    [Abstract] [Full Text] [Related]

  • 12. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z, Hartman C, Livnat G, Shteinberg M, Elenberg Y.
    J Pediatr Gastroenterol Nutr; 2019 Feb 19; 68(2):282-284. PubMed ID: 30640865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Guidance on the interpretation of faecal calprotectin levels in children.
    Orfei M, Gasparetto M, Hensel KO, Zellweger F, Heuschkel RB, Zilbauer M.
    PLoS One; 2021 Feb 19; 16(2):e0246091. PubMed ID: 33571226
    [Abstract] [Full Text] [Related]

  • 16. Calprotectin in cystic fibrosis.
    Rumman N, Sultan M, El-Chammas K, Goh V, Salzman N, Quintero D, Werlin S.
    BMC Pediatr; 2014 May 29; 14():133. PubMed ID: 24885444
    [Abstract] [Full Text] [Related]

  • 17. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L, Aksnes L, Fluge G.
    Eur J Nutr; 2002 Aug 29; 41(4):148-52. PubMed ID: 12242582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B, Amato A, Majo F, Ferrari G, Quattrucci S, Minicucci L, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M, Gruppo di lavoro RIFC.
    Epidemiol Prev; 2019 Aug 29; 43(4S1):1-36. PubMed ID: 31370382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.